P0751-FM.qxd 07/23/05 12:25 AM Page ix C ONTRIBUTORS Numbers in parenthesis indicate the pages on which the author’s con- tributions begin. DAVIDAPPELGATE(245), U.S. Geological Survey, Reston, Virginia 20192 ALEXANDRAJ. BARAN(139), A.J. Baran Consulting Inc., Palo Alto, California 94025 RONCOHEN(97), Acorda Therapeutics, New York, New York 10532 MARK D. DIBNER (47), BioAbility, Research Triangle Park, North Carolina 27709 PETERDRAKE(71), Mayflower Partners, Chicago, Illinois 60610 SUEGOETINCKAMBROSE(27), The Dallas Morning News, Dallas, Texas 75214 MARYANNGRAY(79), Gray Strategic Advisors, New York, New York 10023 GENEVIEVEHADDAD(277), Air Force Office of Scientific Research, Bolling Air Force Base, Washington, D.C. 20332 CAROL HALL (217), BioVenture Consultants, Chestnut Hill, Massachusetts 02467 PHILIP W. HAMMER (117), The Franklin Center, The Franklin Institute Science Museum, Philadelphia, Pennsylvania 19103 BENTE HANSEN (205), Bente Hansen & Associates, San Diego, California 92130 ix P0751-FM.qxd 07/23/05 12:25 AM Page x x Contributors GINA LENTO (263), New Zealand Trade & Enterprise, Auckland, New Zealand ROGER LONGMAN (39), Windover Information, Inc., South Norwalk, Connecticut 06856 ERIN HALL MEADE (161), Life Alaska Donor Services, Anchorage, Alaska 99507 ELIZABETH D. MOYER (125), M/P Biomedical Consultants, LLC, Mill Valley, California 94941 DEEPAPAKIANATHAN(61), Delphi Bioventures, Menlo Park, California 94025 RONALDPEPIN(107), Medarex, Inc., Princeton, New Jersey 08543 CLAYTON R. RANDALL (15), Formerly with PE Applied Systems, Foster City, California 94404 CYNTHIA ROBBINS-ROTH (1, 291), BioVenture Consultants, San Mateo, California 94403 ROBERT ROTH (149), THE WEINBERG GROUP INC., San Francisco, California 94105 TONY RUSSO (191), Noonan Russo, Euro RSCG NRP, New York, New York 10016 GAILSCHECHTER(227), BioIntelligence, San Francisco, California 94115 PAULA SZOKA (177), University of Washington Technology Transfer, University of Washington, Seattle, Washington 98105 P0751-FM.qxd 07/23/05 12:25 AM Page xi P REFACE When I began my path toward becoming an academic scientist back in col- lege, I never dreamed that I would stray so far from that expected fate. My travels took me through worlds I had never even considered—business development, journalism, publishing, running small businesses, and being an independent consultant. While I wandered far from my original objective, science remained the core motivation behind all of these career changes. Even today, several decades after I began my biology major at Bates College (Lewiston, Maine), my love of discovery, learning about new areas of sci- ence, and spending time with scientists is the core driver for all of my activ- ities. The only real change is that my focus is now bringing that science into the rest of the world. When I began this voyage there were few road signs to follow—biolog- ical scientists simply did not leave the academic lab back in the 1970s and early 1980s. I had to forge my own path from the bench to the boardroom. Today, I have the chance to be a mentor to others who are making the same trip. My fellow “scientists gone bad” and I are deluged with phone calls and e-mails from graduate students, post-doctorates, tenured professors, and industry scientists who, for a wide range of reasons, are looking for clues to life outside the lab. I hope this book inspires them to make the leap. This book is dedicated to all of those who helped me in my evolution, and most especially to Dr. Steve Bennett, the M.D./Ph.D. who first led me into the world of venture capital; Brook Byers, who helped build an entire new industry around science and who supported my early writing activities; Dr. Stelios Papadopoulos, and academic scientist turned banker who helped finance that new industry; Joan O’C. Hamilton, who taught me important lessons about journalism; Dr. Steve Spencer, who watched way too many xi P0751-FM.qxd 07/23/05 12:25 AM Page xii xii Preface episodes of The A Team with me as I tortured myself over leaving the lab; Stefan Borg, who bravely turned a bench scientist into a business develop- ment maven; Dr. Carol Hall, my longtime friend and partner in BioVenture Consultants, who forced me to see the beauty in finance and the synergy achieved by two diverse minds working together; and most of all, my hus- band, Robert Roth, an M.D./Ph.D. whose love and support gave me courage as I headed into uncharted territory—and who has since made that same journey himself.